Audrey® M (Medium) (1 x 10 mL) | South Korea

Short Description

A versatile, mid-density macro-volumizing Hyaluronic Acid dermal and body filler formulated with 20 mg/mL of cross-linked HA and multi-stage cohesive polymer technology. Packaged in an economical 10 mL high-capacity presentation, Audrey® M (Medium) is engineered for mid-to-deep subcutaneous, subdermal, and supra-fascial placement, delivering balanced viscoelastic lift ($G’$), smooth dynamic tissue integration, and natural contour replenishment for large-scale facial soft-tissue restoration, dorsal hand rejuvenation, and body contour smoothing lasting 10 to 14 months.

Detailed Description

Audrey® M (Medium) 10 mL is an advanced, sterile, non-pyrogenic physiological cross-linked sodium hyaluronate injectable manufactured in South Korea (Maypharm). Positioned as the supple, highly adaptable counterpart to the dense, bone-mimetic Audrey H (Hard), Audrey M is engineered for anatomical zones that require substantial volumetric replenishment without rigid firmness or palpable borders.

Synthesized from non-animal bio-fermented hyaluronic acid, Audrey M utilizes a multi-staged 3D hydrogel cross-linking process calibrated to balance elastic support with fluid shear-thinning. This cohesive rheological profile enables the hydrogel to distribute evenly throughout subcutaneous tissue compartments, moving dynamically with muscle action and tissue flexion rather than resisting it stiffly. It provides a soft, natural tactile feel ideal for smoothing broad soft-tissue depressions, restoring deflated subcutaneous fat pads, and evening out contour transitions.

Subjected to exhaustive multi-stage dialysis and purification protocols, unreacted BDDE cross-linker monomers and bacterial endotoxins are reduced to non-detectable trace levels. The resulting hydrogel minimizes post-procedure tissue swelling, erythema, and immune reactivity. With its generous 10 mL syringe format, Audrey M enables practitioners to cover extensive surface areas—such as bilateral midface restoration, dorsal hands, or body contour blending—in a single, cost-effective treatment session.

Treatment Areas & Indications

• Midface Soft-Tissue Replenishment & Broad Facial Volumization:

  • Submalar triangle hollow filling and diffuse midface fat pad restoration

  • Deep temporal fossa restoration (temple lifting with soft, natural transitions)

  • Accordion line smoothing and lateral cheek soft-tissue redensification

  • Severe nasolabial fold effacement (mid-to-deep subcutaneous placement)

• Body Contouring & Soft-Tissue Deficit Smoothing:

  • Smoothing and blending lateral pelvic hollows (hip dip refinement)

  • Correction of post-liposuction surface unevenness and cannula track indentations

  • Filling of traumatic atrophic scar depressions and subcutaneous soft-tissue deficits

  • Soft-tissue blending over the upper-outer gluteal perimeter

• Dorsal Hand Rejuvenation:

  • Subcutaneous volume replenishment on the back of the hands, concealing prominent veins and extensor tendons

Key Clinical Advantages

• High-Capacity 10 mL Presentation: Eliminates the logistical inefficiency and packaging waste of opening multiple 1.0 mL or 2.0 mL syringes, providing high clinical utility and cost efficiency for large-area treatments.

• Balanced Rheological Adaptability: Formulated with a moderate elastic modulus ($G’$) and low extrusion force, allowing the gel to blend seamlessly into soft-tissue planes without forming rigid edges or palpable nodules.

• Natural Dynamic Feel: Unlike high-density structural fillers that mimic bone, Audrey M yields a soft, pliable finish that flexes naturally under skin movement and dynamic shear.

• Exhaustive Dialysis Purification: Rigorous washing cycles eliminate residual cross-linkers and bacterial proteins, significantly reducing post-treatment edema, erythema, and downtime.

• Pure Lidocaine-Free Formulation: Allows practitioners total clinical freedom to customize regional nerve blocks, local infiltration, or cannula-assisted lidocaine/saline blending per individual patient needs.

• Smooth Microcannula Glide: Extrudes evenly through 18G–21G body cannulas or 22G–25G facial cannulas, providing continuous extrusion pressure and uniform retrograde fanning.

• Dependable In Vivo Longevity: Densely cross-linked HA chains resist rapid enzymatic degradation by hyaluronidase, maintaining soft-tissue volume for 10 to 14 months.

Technical Specifications

Professional Advisory: Audrey® M 10 mL is a prescription-grade medical injectable intended strictly for certified dermatologists, plastic surgeons, and credentialed aesthetic physicians skilled in cannula-based soft-tissue augmentation, subdermal anatomy, and vascular safety protocols. Injection into the breast parenchyma, glabella, periorbital zone, or superficial papillary dermis is strictly contraindicated.